QQ客服 官方微博 反馈留言

	The value of the combination of hemoglobin, albumin, lymphocyte and platelet in predicting platinum-based chemoradiotherapy response in male patients with esophageal squamous cell carcinoma
	Cong, Lihong; Hu, Likuan
刊名	INTERNATIONAL IMMUNOPHARMACOLOGY
	2017
卷号	46页码:75-79
关键词	Hemoglobin Albumin Lymphocyte Platelet Definitive chemoradiotherapy Esophageal cancer
DOI	10.1016/j.intimp.2017.02.027
URL标识	查看原文
公开日期	[db:dc_date_available]
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/4586039
专题	山东大学
作者单位	Shandong Univ, Qilu Hosp, Dept Radiat Oncol, Wenhuaxi Rd 107, Jinan 250012, Shandong, Peoples R China.
推荐引用方式 GB/T 7714	Cong, Lihong,Hu, Likuan. The value of the combination of hemoglobin, albumin, lymphocyte and platelet in predicting platinum-based chemoradiotherapy response in male patients with esophageal squamous cell carcinoma[J]. INTERNATIONAL IMMUNOPHARMACOLOGY,2017,46:75-79.
APA	Cong, Lihong,&Hu, Likuan.(2017).The value of the combination of hemoglobin, albumin, lymphocyte and platelet in predicting platinum-based chemoradiotherapy response in male patients with esophageal squamous cell carcinoma.INTERNATIONAL IMMUNOPHARMACOLOGY,46,75-79.
MLA	Cong, Lihong,et al."The value of the combination of hemoglobin, albumin, lymphocyte and platelet in predicting platinum-based chemoradiotherapy response in male patients with esophageal squamous cell carcinoma".INTERNATIONAL IMMUNOPHARMACOLOGY 46(2017):75-79.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。